Relevant bibliographies by topics / NSCLP / Books

Books on the topic 'NSCLP'

To see the other types of publications on this topic, follow the link: NSCLP.
Author: Grafiati
Published: 11 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 25 books for your research on the topic 'NSCLP.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

U.S. Army Chemical Materiel Destruction Agency., ed. Non-Stockpile Chemical Materiel Program: NSCMP. [Aberdeen Proving Ground, MD: U.S. Army Chemical Materiel Destruction Agency, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

U.S. Army Chemical Materiel Destruction Agency., ed. Non-Stockpile Chemical Materiel Program: NSCMP. [Aberdeen Proving Ground, MD: U.S. Army Chemical Materiel Destruction Agency, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

U.S. Army Chemical Materiel Destruction Agency, ed. Non-Stockpile Chemical Materiel Program: NSCMP. [Aberdeen Proving Ground, MD: U.S. Army Chemical Materiel Destruction Agency, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

U.S. Army Chemical Materiel Destruction Agency, ed. Non-Stockpile Chemical Materiel Program: NSCMP. [Aberdeen Proving Ground, MD: U.S. Army Chemical Materiel Destruction Agency, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Cappuzzo, Federico. Guide to Targeted Therapies: EGFR mutations in NSCLC. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-03059-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kim, Ho-jung. array-CGH rŭl iyong han piso sepʻo pʻyeam ŭi chogi chaebal pʻyojija mit chindan mohyŏng kaebal =: Development of early-recurrence detection marker and diagnostic model using array-CGH in NSCLC. [Seoul]: Pogŏn Pokchibu, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Cappuzzo, Federico. Guide to Targeted Therapies : EGFR mutations in NSCLC: EGFR mutations in NSCLC. Adis, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Non-Stockpile Chemical Materiel Program: NSCMP. [Aberdeen Proving Ground, MD: U.S. Army Chemical Materiel Destruction Agency, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Krawczyk, Paweł Adam, Qing Zhou, Rafal Dziadziuszko, and Natasha Leighl, eds. Issues and Challenges in NSCLC Immunotherapy. Frontiers Media SA, 2021. http://dx.doi.org/10.3389/978-2-88971-816-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Northumberland Strait Crossing Project (NSCP). [Washington, DC]: Federal Highway Administration, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

Huang, Meijuan, Hongbo Hu, Qian Chu, Yanyan Lou, and Yong He, eds. Immunotherapy for NSCLC with Oncogenic Driver Variants. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-83250-306-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Cassidy, Jim, Donald Bissett, Roy A. J. Spence OBE, Miranda Payne, Gareth Morris-Stiff, and Madhumita Bhattacharyya. Breast cancer. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199689842.003.0014_update_001.

Full text
Abstract:
Thoracic cancer examines the epidemiology, aetiology, and role of screening and prevention in the reduction of deaths from lung cancer, the majority caused by cigarette smoking. The pathology and genetics of lung cancer, with particular note of the driver mutations, are followed by the symptoms and signs of the disease. Appropriate investigations are described to stage the tumour. The optimum treatment for localised non-small cell lung cancer (NSCLC) is surgical resection, followed in some cases by adjuvant chemotherapy. However, most cases present with disease too advanced for surgery, and for these chemotherapy and radiotherapy are appropriate. Metastatic NSCLC can be treated with platinum based doublet chemotherapy with modest palliative benefits. Metastatic NSCLC with specific driver mutations are amenable to control by targeted therapy. Locally advanced NSCLC is often treated with similar chemotherapy and radiotherapy, ideally administered concurrently, to achieve symptom relief but also improved survival rates. Short course simple radiotherapy offers symptom relief in patients not fit for chemotherapy. Patients with localised NSCLC who are not fit for surgery, may benefit from radical radiotherapy, particularly stereotactic radiotherapy. Small cell lung cancer (SCLC) is characterised by almost universal systemic spread, so that surgery is rarely appropriate. Staging is similar to NSCLC, and chemotherapy is the mainstay of treatment, usually cisplatin or carboplatin combined with etoposide. When possible, this is combined with concurrent thoracic irradiation covering all radiological sites of disease. Prophylactic cranial irradiation reduces the risk of CNS disease. Malignant pleural mesothelioma is caused by occupational asbestos exposure. Symptoms and signs, investigation and staging, and management are discussed. Thymic tumours, their pathology, presenting symptoms including paraneoplastic syndromes, investigation, staging and treatment are reviewed.
APA, Harvard, Vancouver, ISO, and other styles
13

Cappuzzo, Federico. Guide to Targeted Therapies: Egfr Mutations in Nsclc. Springer International Publishing AG, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
14

Cappuzzo, Federico. Guide to Targeted Therapies: EGFR Mutations in NSCLC. Springer, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

Troncone, Giancarlo, Julia Rotow, Parneet Cheema, and Pasquale Pisapia. Fast Facts: EGFR Exon 20 Insertion Mutations in NSCLC. Karger AG, S., 2022.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
16

Faber, Anthony. Overcoming Resistance to EGFR Inhibitors in EGFR Mutant NSCLC. Elsevier Science & Technology Books, 2021.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
17

Troncone, Giancarlo, Julia Rotow, Parneet Cheema, and Pasquale Pisapia. Fast Facts: EGFR Exon 20 Insertion Mutations in NSCLC. Karger AG, S., 2022.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
18

Faber, Anthony. Overcoming Resistance to EGFR Inhibitors in EGFR Mutant NSCLC. Elsevier Science & Technology, 2022.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
19

Malapelle, Umberto, Etienne Giroux Leprieur, Christian Rolfo, Paul Takam Kamga, and Marius Tresor Chiasseu, eds. Emerging Biomarkers for NSCLC: Recent Advances in Diagnosis and Therapy. Frontiers Media SA, 2021. http://dx.doi.org/10.3389/978-2-88966-915-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Erridge, Sara C., Elizabeth Toy, and Sorcha Campbell. Radiotherapy for thoracic tumours. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199696567.003.0005.

Full text
Abstract:
Chapter 5 discusses two main subtypes of lung cancer; small cell (SCLC) and non-small cell (NSCLC). However, the management is becoming increasingly similar so the general principles of lung cancer radiotherapy will be discussed first, followed by the specific features of management of the two pathological entities.
APA, Harvard, Vancouver, ISO, and other styles
21

Sun, Shi-Yong, and Chunxia Su, eds. Challenges and Opportunities of TKIs in the Treatment of NSCLC Patients With Uncommon Mutations. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-88976-866-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Parikh, Ravi B. Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancer (NSCLC). 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
23

Hirsh, Vera, and Barbara Melosky, eds. The Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine. Frontiers Media SA, 2015. http://dx.doi.org/10.3389/978-2-88919-543-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Mohamed, Sherif. Cell Cycle-Related Proteins in Mediastinal Lymph Nodes of Patients with N2-Nsclc Obtained by Ebus-Tbna. Independently Published, 2018.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
25

Hirsh, Vera, and Barbara Melosky, eds. Update on the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine. Frontiers Media SA, 2018. http://dx.doi.org/10.3389/978-2-88945-397-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'NSCLP' for other source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography